6,380,248: Metal-thiols as immunomodulating agents
6,380,235: Benzimidazolones and analogues
6,380,223: Glucocorticoid receptor modulators
6,380,211: Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
6,380,204: Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions
6,380,198: Use of flunarizine for the topical treatment of glaucoma
6,380,193: Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
6,380,166: Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5 -ols
6,379,726: Edible, water-solubility resistant casein masses
6,379,674: Use of herpes vectors for tumor therapy
6,379,663: Immunity enhancing lactic acid bacteria
6,376,517: Pipecolic acid derivatives for vision and memory disorders
6,376,502: Osteoporosis compounds
6,376,247: Mammalian pro-apoptotic Bok genes and their uses
6,376,199: Methods to diagnose a required regulation of trophoblast invasion
6,376,169: Method for diagnosing a vascular condition
6,375,979: S(+) desmethylselegiline and its use in transdermal delivery compositions
6,375,962: Barrier cream comprising hexamethylenetetramine or derivative thereof
6,372,759: Antithrombotic agents
6,372,745: 2,3,4,4A-tetrahydro-1H-pyrazino[1,2-A]quinoxalin-5(6H)one derivatives
6,372,726: Methods of cancer treatment using NAALADase inhibitors
6,372,498: Methods, systems, and kits for intravascular nucleic acid delivery
6,372,207: IFNAR2/IFN complex
6,369,201: Myostatin multimers
6,369,193: Contulakin-G, analogs thereof and uses therefor
6,369,106: Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
6,369,062: Sustained release ranolazine formulations
6,369,056: Cyclic urea and cyclic amide derivatives
6,368,816: Regulation of intracellular glucocorticoid concentrations
6,368,806: Marker assisted identification of a gene associated with a phenotypic trait
6,368,787: Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
6,365,796: Transgenic UCP2 knockout mouse and use thereof
6,365,628: Fatty analogues for the treatment of diabetes
6,365,598: Pyrroloquinolines for treatment of obesity
6,365,576: Method for inhibiting herpes infection
6,365,385: Methods of culturing and encapsulating pancreatic islet cells
6,365,337: Genes encoding neuronal voltage-gated calcium channel gamma subunits
6,365,185: Self-destructing, controlled release peroral drug delivery system
6,365,175: Petroselinic acid and its use in food
6,365,149: Porous tissue scaffoldings for the repair or regeneration of tissue
6,365,132: Methods and compositions for whitening teeth
6,364,845: Methods for diagnosing visuospatial disorientation or assessing visuospatial orientation capacity
6,362,392: Nude mouse model for the growth and treatment of human neurally-derived tumors
6,362,236: Inhibition of lipoprotein oxidation
6,362,197: Compositions and method for treatment of cough
6,362,194: Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
6,361,948: Prognostic compositions for prostate cancer and methods of use thereof
6,361,319: Acid resistant film forming dental composition and method of use
6,359,158: Methods and products related to 16-HETE analogs
: multiple decision trees
6,059,724: System for predicting future health
6,055,539: Method to reduce I/O for hierarchical data partitioning methods
6,055,295: Method and apparatus for automatic collimation in x-ray peripheral imaging
6,034,697: Interpolation between relational tables for purposes of animating a data visualization
6,028,959: Incremental ideographic character input method
6,026,399: System and method for selection of important attributes
6,026,189: Method of recognizing objects within two-dimensional and three-dimensional images
6,025,128: Prediction of prostate cancer progression by analysis of selected predictive parameters
:
:
:
:
--:
